Dejan K Filipas

MD | Urology Resident @UKEHamburg and Former Research Fellow @CSPH_BWH | @BWHUrology

[Malte W. Vetterlein @mwvetterlein]

Urorectal fistulas are rare but devastating. Our open access @BJUIjournal study shows that open surgical repair offers durable closure & high satisfaction.
Quality of life outcomes matter as much as surgical success. https://t.co/9A3Lr3BHjV @JakobFelin @n_roessler @DkFilipas

[Malte W. Vetterlein @mwvetterlein]

Thrilled to publish first results from a study that started almost 8 years ago: standardized morbidity & PROMs reporting after #RC. Short-term morbidity does not appear to impact 6-mo #HRQOL.
https://t.co/fLSQBZPKic

@m_koelker @jakobfelin @mvdeimling @apachollek @fluebbersmeyer

[Malte W. Vetterlein @mwvetterlein]

Check out our collaborative effort to develop evidence-based clinical guidance on using @OptilumeDCB for #urethralstrictures. Promising device, but more data is needed for tx beyond @FDA approved and @Uroweb / @AmerUrological recommended indications. https://t.co/VWIy3KRwsO

[IMORU IX @IMORU]

Congrats to @mwvetterlein on a brilliant MANTA bulbar urethroplasty at IMORU XI! 3 days of top-notch live reconstructive surgeries here in Hamburg. Truly a world-class meeting. @UKEHamburg #Urology #LiveSurgery #Urethroplasty

[IMORU IX @IMORU]

The @IMORU 2025 program is set! Join us at @UKEHamburg for 20 live & 14 semi-live surgeries, expert lectures & interactive discussions with 30+ top international reconstructive surgeons. Register now: https://t.co/7qVHYwLzG6 #IMORU2025

[Jakob Klemm @JakobFelin]

Patient satisfaction suggests perineal urethrostomy shouldn’t be just a last resort for complex stricture cases or elderly patients. Check out our latest paper in @JUrology https://t.co/JQFuJ2XWbC @mwvetterlein @DrShariat @EAU_YAURecon @SocietyGURS @UKEHamburg

[Jakob Klemm @JakobFelin]

Excited to share our latest work on female non-obstetric urogenital fistula repair! We dive into long-term patient-reported outcomes and provide a comprehensive review. Proud to collaborate with @mwvetterlein @DrShariat @UKEHamburg on this important work. R. Dahlem, M. Fisch.

[Nature Biotechnology @NatureBiotech]

Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism https://t.co/pjdFYlDSAd

[JNCI @JNCI_Now]

Study notes increasing trends in non-operative management for small renal masses. Findings show significant variances in expectant management and focal ablation by year of diagnosis and race. From @DkFilipas et al.

Read here: https://t.co/S4a48Jk4Aw

[Dejan K Filipas @DkFilipas]

Explore our latest study on how the COVID-19 pandemic has led to workflow improvements in prostate cancer care, significantly optimizing the time from diagnosis to counseling.

Read more at:
https://t.co/LgAkT6VwDk

@dr_steuber
@Tilki_De
@MartiniKlinik

[UroToday.com @urotoday]

Midlife baseline PSA as a predictor of lethal #ProstateCancer: Racial differences between Black and White men. Presented by @ChiarelliGiuse @HumanitasMilano. #AUA24 written coverage by @RKSayyid @UofT > https://t.co/4wjR3zpbed

[BJU International @BJUIjournal]

In cN+ #BladderCancer treated with cisplatin-based induction CTX followed by RC we found no difference in #PathologicalResponse and OS/CSS between delivering three and four cycles - @mvdeimling @LAUrology_NL et al

https://t.co/NHek4zHgvj

[Markus von Deimling @mvdeimling]

We need procedure-specific comorbidity assessments, as standard comorbidity indices are too generic to predict postop. morbidity! Check out our latest paper https://t.co/7znGGoDTsH
@mwvetterlein @DrShariat @MichaelRink_MD @JakobFelin @M_Koelker @VMS78880496 @FredKoenig @PAEGild

[European Urology Oncology @EurUrolOncol]

Articles in Press: The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality

https://t.co/A30emxRN8f

@mdlabban @EdoardoBeatrici @DkFilipas @DrChoueiri @adamkibel_uro @Putnam_Cole @qdtrinh

#UroSoMe

[NatureRevClinOncol @NatRevClinOncol]

In a News and Views now published online, Jakob Klemm, Ekaterina Laukhtina & Shahrokh Shariat discuss a trial of addition of nivolumab to neoadjuvant therapy for muscle-invasive #bladdercancer with results published in @NatureMedicine: https://t.co/XNpETs6rgI

[Stacy Loeb, MD @LoebStacy]

Hot off the press in @JNCI_Now 🌏 Recognition of #Climatechange as a personal health threat is significantly associated w cancer screening intent - thx for the collaboration @JasonZhiyuQian @EdoardoBeatrici @qdtrinh @adamkibel_uro @hiyer_epi @Putnam_Cole https://t.co/daDWFYCIPu

[European Urology @EUplatinum]

Uncovering the Changing Treatment Landscape for Low-risk Prostate Cancer in the USA from 2010 to 2020: Insights from the National Cancer Data Base

https://t.co/gKdlDSVpOj

@EdoardoBeatrici @mdlabban @DkFilipas @GLughezzani @NBuffi @adamkibel_uro @Putnam_Cole @qdtrinh

[BJU International @BJUIjournal]

Online now: Continent Diversion is Losing its Momentum: a Nationwide Trend Analysis from Germany 2005–2021 by @JakobFelin @mwvetterlein et al.

https://t.co/23vPWtG3Dz

[Dejan K Filipas @DkFilipas]

@drphil_urology @qdtrinh @Putnam_Cole Great work by our team @EdoardoBeatrici @Nolazco_JI @JasonZhiyuQian @benvstone @mdlabban Thank you for the great collaboration @drphil_urology

[Phillip Pierorazio @drphil_urology]

getting better at #activesurveillance for small renal masses

90% improvement since 2010, but only 10% getting AS

great work f @DkFilipas @qdtrinh @Putnam_Cole

The National Utilization of Non-Operative Management for Small Renal Masses Over 10 Years https://t.co/AQf2F3mm5U